drugset
drugset / Trial / NCT00721474

Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

NCT00721474 ↗

Phase 1 Completed 24 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

A Study to determine if a high-fat meal has an effect on the pharmacokinetics of bosutinib.

Timeline

Start
2008-09
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosutinib Small molecule — Oral

Indications

No indication recorded.